JPWO2022186282A1 - - Google Patents
Info
- Publication number
- JPWO2022186282A1 JPWO2022186282A1 JP2023503916A JP2023503916A JPWO2022186282A1 JP WO2022186282 A1 JPWO2022186282 A1 JP WO2022186282A1 JP 2023503916 A JP2023503916 A JP 2023503916A JP 2023503916 A JP2023503916 A JP 2023503916A JP WO2022186282 A1 JPWO2022186282 A1 JP WO2022186282A1
- Authority
- JP
- Japan
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
- C12N15/09—Recombinant DNA-technology
- C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
- C12N15/79—Vectors or expression systems specially adapted for eukaryotic hosts
- C12N15/85—Vectors or expression systems specially adapted for eukaryotic hosts for animal cells
- C12N15/86—Viral vectors
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- A61K38/18—Growth factors; Growth regulators
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- A61K38/18—Growth factors; Growth regulators
- A61K38/1808—Epidermal growth factor [EGF] urogastrone
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- A61K38/18—Growth factors; Growth regulators
- A61K38/1833—Hepatocyte growth factor; Scatter factor; Tumor cytotoxic factor II
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K48/00—Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases; Gene therapy
- A61K48/0008—Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases; Gene therapy characterised by an aspect of the 'non-active' part of the composition delivered, e.g. wherein such 'non-active' part is not delivered simultaneously with the 'active' part of the composition
- A61K48/0025—Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases; Gene therapy characterised by an aspect of the 'non-active' part of the composition delivered, e.g. wherein such 'non-active' part is not delivered simultaneously with the 'active' part of the composition wherein the non-active part clearly interacts with the delivered nucleic acid
- A61K48/0033—Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases; Gene therapy characterised by an aspect of the 'non-active' part of the composition delivered, e.g. wherein such 'non-active' part is not delivered simultaneously with the 'active' part of the composition wherein the non-active part clearly interacts with the delivered nucleic acid the non-active part being non-polymeric
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K48/00—Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases; Gene therapy
- A61K48/005—Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases; Gene therapy characterised by an aspect of the 'active' part of the composition delivered, i.e. the nucleic acid delivered
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/18—Drugs for disorders of the alimentary tract or the digestive system for pancreatic disorders, e.g. pancreatic enzymes
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
- A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/475—Growth factors; Growth regulators
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/475—Growth factors; Growth regulators
- C07K14/4753—Hepatocyte growth factor; Scatter factor; Tumor cytotoxic factor II
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/475—Growth factors; Growth regulators
- C07K14/485—Epidermal growth factor [EGF], i.e. urogastrone
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
- A61K35/66—Microorganisms or materials therefrom
- A61K35/76—Viruses; Subviral particles; Bacteriophages
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
- A61K35/66—Microorganisms or materials therefrom
- A61K35/76—Viruses; Subviral particles; Bacteriophages
- A61K35/761—Adenovirus
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2710/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA dsDNA viruses
- C12N2710/00011—Details
- C12N2710/10011—Adenoviridae
- C12N2710/10311—Mastadenovirus, e.g. human or simian adenoviruses
- C12N2710/10341—Use of virus, viral particle or viral elements as a vector
- C12N2710/10343—Use of virus, viral particle or viral elements as a vector viral genome or elements thereof as genetic vector
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2750/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssDNA viruses
- C12N2750/00011—Details
- C12N2750/14011—Parvoviridae
- C12N2750/14111—Dependovirus, e.g. adenoassociated viruses
- C12N2750/14141—Use of virus, viral particle or viral elements as a vector
- C12N2750/14143—Use of virus, viral particle or viral elements as a vector viral genome or elements thereof as genetic vector
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Engineering & Computer Science (AREA)
- General Health & Medical Sciences (AREA)
- Genetics & Genomics (AREA)
- Organic Chemistry (AREA)
- Gastroenterology & Hepatology (AREA)
- Medicinal Chemistry (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Zoology (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Molecular Biology (AREA)
- Diabetes (AREA)
- Biotechnology (AREA)
- Epidemiology (AREA)
- Biochemistry (AREA)
- Biophysics (AREA)
- General Engineering & Computer Science (AREA)
- Wood Science & Technology (AREA)
- Immunology (AREA)
- Biomedical Technology (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Toxicology (AREA)
- Endocrinology (AREA)
- Obesity (AREA)
- Hematology (AREA)
- Physics & Mathematics (AREA)
- Plant Pathology (AREA)
- Microbiology (AREA)
- Emergency Medicine (AREA)
- Virology (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP2021033714 | 2021-03-03 | ||
| JP2021145796 | 2021-09-07 | ||
| PCT/JP2022/008898 WO2022186282A1 (ja) | 2021-03-03 | 2022-03-02 | 糖尿病に対するhb-egf遺伝子治療 |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JPWO2022186282A1 true JPWO2022186282A1 (cg-RX-API-DMAC7.html) | 2022-09-09 |
| JPWO2022186282A5 JPWO2022186282A5 (cg-RX-API-DMAC7.html) | 2024-02-08 |
Family
ID=83154306
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2023503916A Pending JPWO2022186282A1 (cg-RX-API-DMAC7.html) | 2021-03-03 | 2022-03-02 |
Country Status (12)
Families Citing this family (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN107106542B (zh) | 2014-10-20 | 2020-05-08 | 奥伊斯特普安生物制药公司 | 治疗眼部病状的方法 |
| JP7868817B2 (ja) * | 2024-04-02 | 2026-06-02 | 国立大学法人 鹿児島大学 | 糖尿病に対するsHB-EGF強化治療 |
Citations (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2007037514A1 (ja) * | 2005-09-28 | 2007-04-05 | Kagoshima University | ヘパリン結合性上皮増殖因子様増殖因子の新規医薬用途 |
| WO2009013794A1 (ja) * | 2007-07-20 | 2009-01-29 | Hideo Toyoshima | インスリン分泌誘導剤及び膵臓β細胞増加促進剤 |
Family Cites Families (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JP2007223939A (ja) * | 2006-02-22 | 2007-09-06 | Kobe Univ | エネルギー代謝促進因子としてのhb−egfの使用 |
| JP6711495B1 (ja) | 2019-05-27 | 2020-06-17 | 株式会社ナイスリー | 車両用盗難防止装置 |
| JP2021033714A (ja) | 2019-08-26 | 2021-03-01 | 東芝テック株式会社 | 商品販売データ処理装置及びプログラム |
| JP7040807B2 (ja) | 2020-03-17 | 2022-03-23 | 株式会社オリンピア | 遊技機 |
-
2022
- 2022-03-02 US US18/548,807 patent/US20240173381A1/en active Pending
- 2022-03-02 CA CA3212726A patent/CA3212726A1/en active Pending
- 2022-03-02 BR BR112023017808A patent/BR112023017808A2/pt unknown
- 2022-03-02 WO PCT/JP2022/008898 patent/WO2022186282A1/ja not_active Ceased
- 2022-03-02 AU AU2022230492A patent/AU2022230492A1/en active Pending
- 2022-03-02 PH PH1/2023/552425A patent/PH12023552425A1/en unknown
- 2022-03-02 KR KR1020237033566A patent/KR20240004273A/ko active Pending
- 2022-03-02 EP EP22761939.2A patent/EP4302785A4/en active Pending
- 2022-03-02 JP JP2023503916A patent/JPWO2022186282A1/ja active Pending
- 2022-03-02 IL IL305627A patent/IL305627A/en unknown
- 2022-03-02 MX MX2023010315A patent/MX2023010315A/es unknown
-
2023
- 2023-10-02 ZA ZA2023/09227A patent/ZA202309227B/en unknown
Patent Citations (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2007037514A1 (ja) * | 2005-09-28 | 2007-04-05 | Kagoshima University | ヘパリン結合性上皮増殖因子様増殖因子の新規医薬用途 |
| WO2009013794A1 (ja) * | 2007-07-20 | 2009-01-29 | Hideo Toyoshima | インスリン分泌誘導剤及び膵臓β細胞増加促進剤 |
Non-Patent Citations (4)
| Title |
|---|
| KOZAWA, J. ET AL.: "Regenerative and therapeutic effects of heparin-binding epidermal growth factor-like growth factor o", PANCREAS, vol. 31, no. 1, JPN6022012724, 2005, pages 32 - 42, ISSN: 0005793108 * |
| MATSUDA, E. ET AL.: "Safe and low-dose but therapeutically effective adenovirus mediated hepatocyte growth factor gene th", LIFE SCIENCES, vol. 268, no. 119014, JPN6022012722, 4 January 2021 (2021-01-04), pages 1 - 5, ISSN: 0005793107 * |
| SAKAMOTO, K. ET AL.: "Heparin-binding epidermal growth factor-like growth factor and hepatocyte growth factor inhibit chol", INTERNATIONAL JOURNAL OF MOLECULAR MEDICINE, vol. 38, JPN6026004696, 2016, pages 1673 - 1682, ISSN: 0005793110 * |
| 宮川 潤一郎: "膵β細胞のアポトーシス・再生", 別冊・医学のあゆみ, 糖尿病・代謝症候群−STATE OF ARTS 2004−2006, JPN6022012725, 2004, JP, pages 77 - 83, ISSN: 0005793109 * |
Also Published As
| Publication number | Publication date |
|---|---|
| WO2022186282A1 (ja) | 2022-09-09 |
| MX2023010315A (es) | 2023-11-24 |
| ZA202309227B (en) | 2024-06-26 |
| PH12023552425A1 (en) | 2024-02-19 |
| CA3212726A1 (en) | 2022-09-09 |
| US20240173381A1 (en) | 2024-05-30 |
| AU2022230492A1 (en) | 2023-10-19 |
| IL305627A (en) | 2023-11-01 |
| EP4302785A1 (en) | 2024-01-10 |
| BR112023017808A2 (pt) | 2023-09-26 |
| KR20240004273A (ko) | 2024-01-11 |
| EP4302785A4 (en) | 2025-01-29 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CN305861481S (zh) | 玩具(犀牛拖拉车) | |
| CN305862854S (zh) | 吊灯(6838) | |
| CN306008212S (zh) | 浴室柜(艾米系列) | |
| CN306015002S (zh) | 食物处理机主机 | |
| CN306009033S (zh) | 温奶器(雨后款) | |
| CN306004314S (zh) | 减速箱 | |
| CN306006556S (zh) | 口罩(c) | |
| CN306013286S (zh) | 加湿器外罩(灯塔) | |
| CN305945599S (zh) | 包装袋(元皛美白精华面膜) | |
| CN305957900S (zh) | 玩具积木(冰淇淋车) | |
| CN306016070S (zh) | 床头柜(62号) | |
| CN306005238S (zh) | 电热水器(34d) | |
| CN305945339S (zh) | 包装盒(labr焱清啫喱牙膏) | |
| CN305957026S (zh) | 播种机滚子支架 | |
| CN305902779S (zh) | 包装袋(小兰花豆) | |
| CN305934343S (zh) | 风扇 | |
| CN305932020S (zh) | 锅(功能滤油锅) | |
| CN305946987S (zh) | 变频电机(一体式) | |
| CN305872668S (zh) | 硅胶口罩 | |
| CN305943762S (zh) | 杯垫(发光) | |
| CN305853286S (zh) | 玩具变形兽(2) | |
| CN305958385S (zh) | 抽油烟机(f117-5) | |
| CN305866206S (zh) | 包装罐 | |
| CN305929165S (zh) | 八角形组合缸 | |
| CN305868823S (zh) | 扫描仪 |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| A529 | Written submission of copy of amendment under article 34 pct |
Free format text: JAPANESE INTERMEDIATE CODE: A5211 Effective date: 20230830 |
|
| A521 | Request for written amendment filed |
Free format text: JAPANESE INTERMEDIATE CODE: A523 Effective date: 20231016 |
|
| A621 | Written request for application examination |
Free format text: JAPANESE INTERMEDIATE CODE: A621 Effective date: 20250127 |
|
| A131 | Notification of reasons for refusal |
Free format text: JAPANESE INTERMEDIATE CODE: A131 Effective date: 20260210 |
|
| A601 | Written request for extension of time |
Free format text: JAPANESE INTERMEDIATE CODE: A601 Effective date: 20260406 |
|
| A521 | Request for written amendment filed |
Free format text: JAPANESE INTERMEDIATE CODE: A523 Effective date: 20260528 |